Related Experiment Videos
Antifungal triazoles induce malformations in vitro
E Menegola1, M L Broccia, F Di Renzo
1Department of Biology, University of Milan, Italy.
Reproductive Toxicology (Elmsford, N.Y.)
|August 8, 2001
Summary
Flusilazole and fluconazole, triazole-derivative antimycotics, demonstrated teratogenic effects in developing rat embryos. The parental triazole compound showed no significant teratogenic activity in this in vitro study.
Area of Science:
- Toxicology
- Developmental Biology
- Pharmacology
Background:
- Triazole derivatives are widely used as antimycotics in agriculture, clinical settings, and veterinary medicine.
- Understanding the potential teratogenic effects of these compounds is crucial for risk assessment.
Purpose of the Study:
- To conduct an in vitro comparative study of the teratogenic activity of triazole, flusilazole, and fluconazole.
- To evaluate the developmental toxicity of these triazole derivatives on rat embryos.
Main Methods:
- Rat embryos (9.5 days old) were cultured in vitro and exposed to varying concentrations of triazole, flusilazole, and fluconazole.
- Embryos were examined morphologically, histologically, and biochemically after 48 hours of culture.
Main Results:
- Flusilazole and fluconazole induced teratogenic effects, including branchial apparatus abnormalities and cell death, at specific concentrations.
- Triazole exhibited only slight developmental retardation and blood discoloration at the highest concentrations, indicating a lack of teratogenic activity.
Conclusions:
- Flusilazole and fluconazole possess significant teratogenic potential, necessitating caution in their use.
- The parental triazole compound does not appear to be teratogenic based on this in vitro study.